Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 9,080,426	$ 16,808,539
Prepaid research and development	525,532	66,217
Other current assets	207,171	244,021
Total current assets	9,813,129	17,118,777
Deposits	127,534	127,534
Property and equipment, net	19,373	16,377
Right of use asset	315,932	638,786
Total assets	10,275,968	17,901,474
Current liabilities
Accounts payable	1,350,793	953,349
Accrued expenses	1,609,535	850,557
Lease liability, current portion	331,152	332,817
Short-term milestone payable due to Patagonia Pharmaceuticals LLC	1,750,000
Redeemable Series A preferred stock under redemption (Notes 5 and 9)		2,055,348
Total current liabilities	5,041,480	4,192,071
Note payable		37,772
Lease liability		331,152
Other liabilities		73,683
Total liabilities	5,041,480	4,634,678
Commitments and contingencies (Note 7)
Stockholders' equity
Preferred stock par value $0.001; 10,000,000 shares authorized, no shares issued and outstanding as of December 31 2022 and 2021, respectively
Common stock, par value $0.001; 450,000,000 shares authorized; 2,670,856 shares issued and outstanding as of December 31, 2022, and 1,272,383 shares issued and outstanding as of December 31, 2021	148,354	63,619
Additional paid-in capital	53,350,126	42,087,719
Accumulated deficit	(48,263,992)	(28,884,542)
Total stockholders' equity	5,234,488	13,266,796
Total liabilities and stockholders' equity	$ 10,275,968	$ 17,901,474